Immunomorphological specifcity of HER2-low breast cancer

Assessment of tumor infltrating lymphocytes (TiLs) has been recognized as an additional tool for predicting survival in triple negative (TN) and HER2/neu positive (HER2+) subtypes of breast cancer (BC). Recently, BC, including the above-mentioned subtypes and characterized by low/undefined expressio...

Full description

Saved in:
Bibliographic Details
Main Authors: I. V. Mikhailov, E. R. Eremeeva, A. A. Glazkov, I. M. Telezhnikova, G. R. Setdikova, A. S. Balkanov
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2024-11-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/3266
Tags: Add Tag
No Tags, Be the first to tag this record!